NCT02483962View on ClinicalTrials.gov

Venavine Intensive® in the Treatment of Symptoms Associated With Chronic Venous Insufficiency

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Venous Insufficiency
Interventions
OTHER

Gelatine capsule

Gelatine capsules containing no active ingredients.

OTHER

Venavine Intensive®

Gelatine capsules containing 360 mg red vine leaf extract, 60 mg of horse chestnut extract, 35 mg of butchers broom extract and 3,2 mg of vitamin B6.

Trial Locations (1)

2028

University of Johannesburg, Johannesburg

All Listed Sponsors
lead

University of Johannesburg

OTHER

NCT02483962 - Venavine Intensive® in the Treatment of Symptoms Associated With Chronic Venous Insufficiency | Biotech Hunter | Biotech Hunter